Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma

por Pacenta, Holly L, Macy, Margaret E
Publicado 2018

Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children’s Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force

por Pacenta, Holly L., Allen-Rhoades, Wendy, Langenau, David, Houghton, Peter J., Keller, Charles, Heske, Christine M., Deel, Michael D., Linardic, Corinne M., Shern, Jack F., Stewart, Elizabeth, Turpin, Brian, Harrison, Douglas J., Khan, Javed, Mascarenhas, Leo, Skapek, Stephen X., Meyer, William H., Hawkins, Douglas S., Chen, Eleanor Y., Amatruda, James F., Hingorani, Pooja, Laetsch, Theodore W.
Publicado 2021

Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium

por Stefanski, Heather E., Eaton, Anne, Baggott, Christina, Rossoff, Jenna, Verneris, Michael R., Prabhu, Snehit, Pacenta, Holly L., Phillips, Christine L., Talano, Julie-An, Moskop, Amy, Margossian, Steven P., Myers, Gary Douglas, Karras, Nicole A., Brown, Patrick A., Qayed, Muna, Hermiston, Michelle, Satwani, Prakash, Krupski, M. Christa, Keating, Amy K., Wilcox, Rachel, Rabik, Cara A., Fabrizio, Vanessa A., Chinnabhandar, Vasant, Goksenin, A. Yasemin, Curran, Kevin J., Mackall, Crystal L., Laetsch, Theodore W., Schultz, Liora M.
Publicado 2022

Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia

por Moskop, Amy, Pommert, Lauren, Baggott, Christina, Prabhu, Snehit, Pacenta, Holly L., Phillips, Christine L., Rossoff, Jenna, Stefanski, Heather E., Talano, Julie-An, Margossian, Steve P., Verneris, Michael R., Myers, G. Doug, Karras, Nicole A., Brown, Patrick A., Qayed, Muna, Hermiston, Michelle L., Satwani, Prakash, Krupski, Christa, Keating, Amy K., Wilcox, Rachel, Rabik, Cara A., Fabrizio, Vanessa A., Chinnabhandar, Vasant, Goksenin, A. Yasemin, Curran, Kevin J., Mackall, Crystal L., Laetsch, Theodore W., Guest, Erin M., Breese, Erin H., Schultz, Liora M.
Publicado 2022

HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL

por McNerney, Kevin O., Si Lim, Stephanie J., Ishikawa, Kyle, Dreyzin, Alexandra, Vatsayan, Anant, Chen, John J., Baggott, Christina, Prabhu, Snehit, Pacenta, Holly L., Philips, Christine, Rossoff, Jenna, Stefanski, Heather E., Talano, Julie-An, Moskop, Amy, Verneris, Michael, Myers, Doug, Karras, Nicole A., Brown, Patrick, Bonifant, Challice L., Qayed, Muna, Hermiston, Michelle, Satwani, Prakash, Krupski, Christa, Keating, Amy K., Baumeister, Susanne H. C., Fabrizio, Vanessa A., Chinnabhandar, Vasant, Egeler, Emily, Mavroukakis, Sharon, Curran, Kevin J., Mackall, Crystal L., Laetsch, Theodore W., Schultz, Liora M.
Publicado 2023

Mediport use as an acceptable standard for CAR T cell infusion

por Eylon, Maya, Prabhu, Snehit, John, Samuel, King, Maxwell J. M., Bhatt, Dhruv, Curran, Kevin J., Erickson, Courtney, Karras, Nicole A., Phillips, Christine L., Satwani, Prakash, Hermiston, Michelle, Southworth, Erica, Baumeister, Susanne H. C., Talano, Julie-An, MacMillan, Margaret L., Rossoff, Jenna, Bonifant, Challice L., Myers, Gary Doug, Rouce, Rayne H., Toner, Keri, Driscoll, Timothy A., Katsanis, Emmanuel, Salzberg, Dana B., Schiff, Deborah, De Oliveira, Satiro N., Capitini, Christian M., Pacenta, Holly L., Pfeiffer, Thomas, Shah, Niketa C., Huynh, Van, Skiles, Jodi L., Fraint, Ellen, McNerney, Kevin O., Quigg, Troy C., Krueger, Joerg, Ligon, John A., Fabrizio, Vanessa A., Baggott, Christina, Laetsch, Theodore W., Schultz, Liora M.
Publicado 2023